HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy.

Abstract
The roles of the epidermal growth factor receptor (EGFR) signaling pathway in various cancers including breast, bladder, brain, colorectal, esophageal, gastric, head and neck, hepatocellular, lung, neuroblastoma, ovarian, pancreatic, prostate, renal and other cancers have been keenly investigated since the 1980's. While the receptors and many downstream signaling molecules have been identified and characterized, there is still much to learn about this pathway and how its deregulation can lead to cancer and how it may be differentially regulated in various cell types. Multiple inhibitors to EGFR family members have been developed and many are in clinical use. Current research often focuses on their roles and other associated pathways in cancer stem cells (CSCs), identifying sites where therapeutic resistance may develop and the mechanisms by which microRNAs (miRs) and other RNAs regulate this pathway. This review will focus on recent advances in these fields with a specific focus on breast cancer and breast CSCs. Relatively novel areas of investigation, such as treatments for other diseases (e.g., diabetes, metabolism, and intestinal parasites), have provided new information about therapeutic resistance and CSCs.
AuthorsLinda S Steelman, Timothy Fitzgerald, Kvin Lertpiriyapong, Lucio Cocco, Matilde Y Follo, Alberto M Martelli, Luca M Neri, Sandra Marmiroli, Massimo Libra, Saverio Candido, Ferdinando Nicoletti, Aurora Scalisi, Concettina Fenga, Lyudmyla Drobot, Dariusz Rakus, Agnieszka Gizak, Piotr Laidler, Joanna Dulinska-Litewka, Joerg Basecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Giuseppe Montalto, Melchiorre Cervello, Michelle Milella, Agustino Tafuri, Zoya Demidenko, Stephen L Abrams, James A McCubrey
JournalCurrent pharmaceutical design (Curr Pharm Des) Vol. 22 Issue 16 Pg. 2358-88 ( 2016) ISSN: 1873-4286 [Electronic] United Arab Emirates
PMID26947958 (Publication Type: Journal Article, Review)
Chemical References
  • ErbB Receptors
Topics
  • Animals
  • Breast Neoplasms (drug therapy, metabolism, pathology)
  • ErbB Receptors (antagonists & inhibitors, metabolism)
  • Female
  • Humans
  • Neoplastic Stem Cells (drug effects, metabolism, pathology)
  • Signal Transduction (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: